Disease evolution and outcomes in familial AML with germline CEBPA mutations.
暂无分享，去创建一个
J. Gribben | B. Porse | L. Bullinger | K. Döhner | A. Savic | J. Fitzgibbon | R. Hills | J. Cavenagh | C. Chelala | C. Preudhomme | X. Thomas | T. Pabst | N. Uike | C. Nerlov | Aline Renneville | F. V. van Delft | M. Debeljak | B. Schlegelberger | J. Jazbec | E. Wozniak | C. Bödör | Jun Wang | K. Tawana | C. Loveday | J. Treleaven | Panayiotis Georgiades | E. Uglow | N. Asou | P. Ancliff | R. Gale | V. Mialou | B. Mueller | M. Stelljes | S. Iqbal | J. Okosun | S. Araf | Anne-Katrine Frank | Felicia Lauridsen | C. Owen | I. Dokal | Matthew L. Smith | E. Woźniak | Matthew L. Smith | M. Smith | Matthew L. Smith | Felicia B Lauridsen